Abstract:Abstract. It is widely known that both obesity and vitamin D deficiency can lead to increased symptoms of bronchial asthma (ВА) in both children and adults. Obesity is linked to higher levels of pro-inflammatory mediators and lower levels of vitamin D. In turn, vitamin D deficiency is closely related to obesity and can contribute to increased bronchial hyperreactivity, clinical symptoms of BA, and the development of pulmonary fibrosis. The study aimed to determine vitamin D levels in patients with BA, considering their body mass index (BMI), age of onset, and clinical and functional characteristics. Research material and methods. 553 patients with BA were examined. The control group consisted of 95 practically healthy people with no personal or family history of asthma, allergies, or atopy symptoms. All subjects signed a prior informed consent to participate in the study. To determine vitamin D content depending on the BMI, patients were divided into three groups: Group I consisted of 152 patients with normal body weight (NBW), II — 206 overweight patients, III — 195 — with obesity. For the analysis, 2 groups were formed depending on the onset age: 1 group included 271 patients with early onset BA (among them 100 obese patients), 2 — 282 patients with late onset (95 with obesity). The Bioethics Commission of the Educational and Scientific Medical Institute of Sumy State University approved the study. Statistical analysis of the obtained results was carried out using the SPSS-17 program. The results. A study of vitamin D content in patients with BA (n = 553), regardless of the age of onset and BMI, showed a probable decrease in its level (31.9 ± 0.62) compared to practically healthy individuals (43.1 ± 1.04) ng/ml (p = 0.001), which indicates its insufficient level. Given that obesity is associated with vitamin D deficiency, we examined its content depending on BMI. A decrease in the content of vitamin D in patients with BA with NBW and overweight was established to (35.1 ± 1.25) ng/ml and (35.9 ± 0.96) ng/ml, and in patients with BA with obesity to (25.1 ± 0.83) ng/ml, which indicates a connection between BMI and the level of vitamin D. Along with this, it was established that the level of vitamin D was probably lower in patients with early-onset BA — (27.1 ± 0.86 ) ng/ml compared with those in patients with late BA — (36.4 ± 0.78) ng/ml (p = 0.001), with a severe course — (24.7 ± 0.71) ng/ml compared with mild — (39.8 ± 0.78) ng/ml; with a duration of more than 20 years — (26.6 ± 1.20) ng/ml compared to less — (37.7 ± 1.15) ng/ml, with no control — (25.2 ± 0.80) ng/ml compared to complete — (42.4 ± 0.91) ng/ml. Conclusions. The study found that patients with BA had lower levels of vitamin D compared to the control group. Additionally, among BA patients, those with obesity had lower vitamin D levels compared to those with normal body weight and overweight. The study also established that vitamin D levels were lower in patients with early onset BA compared to those with late onset, and in patients with a disease duration of more than 20 years compared to those with a duration of less than 20 years. Finally, the study found that vitamin D levels were lower in BA patients with no control compared to those who had complete control over their BA. Key words: bronchial asthma, obesity, vitamin D, course, control.

Association of vitamin D with disease severity in infants with bronchiolitis

[Association of Vitamin D Concentrations with Juvenile Idiopathic Arthritis].

Maternal-neonatal Vitamin D Status and Related Factors

Evaluation of vitamin D status effect on the outcome of children hospitalized with acute respiratory illnesses at a paediatrics referral hospital, Kenya

A Hospital-Based Study of Vitamin D Levels in Children With Recurrent Respiratory Infections

Vitamin D levels in cord blood of newborn and in blood of infant:a correlation study

Relationship Between Vitamin D Status and Viral Pneumonia in Children

Effect of Vitamin D Supplementation on Moderate to Severe Bronchial Asthma

Serum 25-hydroxyvitamin D levels and immune-related markers in children with asthma

Vitamin D Modulation of the Innate Immune Response to Paediatric Respiratory Pathogens Associated with Acute Lower Respiratory Infections

Association of Cytokine Responses with Disease Severity in Infants with Respiratory Syncytial Virus Infection

The Level of Vitamin D in Patients with Bronchial Asthma Depends on Body Mass Index and Age of Onset of Disease

Expression and significance of serum vitamin D and LL-37 levels in infants with bacterial pneumonia

Exploring the Preventive Potential of Vitamin D against Respiratory Infections in Preschool-Age Children: A Cross-Sectional Study

Evaluation of vitamin D levels in allergic and non-allergic asthma

Vitamin D [ Serum 25(OH) cholecalciferol] Insufficiency is Associated With Childhood Asthma: Recent Case-Control Findings From Bangladesh

Vitamin D levels and clinical outcomes of SARS-CoV-2 Omicron subvariant BA.2 in children: A longitudinal cohort study

Vitamin D status and associations in newborn formula-fed infants during initial hospitalization

Vitamin D status was associated with sepsis in critically ill children A PRISMA compliant systematic review and meta-analysis

Vitamin A level and related clinical factors in preterm infants

Vitamin D Status Was Associated with Sepsis in Critically Ill Children